日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice

肝脏 Akt 磷酸化增加可缓解瘦素缺乏小鼠的葡萄糖不耐受并改善肝功能

Tomer Adar, Meir Mizrahi, Yoav Lichtenstein, Yehudit Shabat, Rizan Sakhnini, Lida Zolotarov, Naim Shehadeh, Yaron Ilan

Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent

类固醇介导的肝脏脂肪变性是 CD1d 依赖性的,而类固醇引起的肝脏坏死、炎症和代谢变化是 CD1d 独立的

Tomer Adar #, Ami Ben Ya'acov #, Yehudit Shabat, Meir Mizrahi, Lida Zolotarov, Yoav Lichtenstein, Yaron Ilan

The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways

鞘氨醇轴在免疫调节中的作用:鞘氨醇激酶 1 和鞘氨醇激酶 2 依赖途径抗炎作用的二分法

Yuval Ishay, Dvorah Rotnemer-Golinkin, Yaron Ilan

Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach

口服抗嗜酸细胞活化趋化因子-1单克隆抗体在肠道中具有生物活性并缓解免疫介导性肝炎:一种新颖的抗炎个性化治疗方法

Tawfik Khoury, Dory Rotnemer-Golinkin, Lidya Zolotarev, Yaron Ilan

Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial

用于治疗溃疡性结肠炎的新型口服重组抗 TNF Alpha 融合蛋白:2a 期临床试验结果

Einat Almon, Yoseph Shaaltiel, Wisam Sbeit, Alex Fich, Doron Schwartz, Mattitiahu Waterman, Mali Szlaifer, Hadar Reuveni, Bat-Chen Amit-Cohen, Sari Alon, Raul Chertkoff, Alona Paz, Yaron Ilan

How Positivity Links With Job Satisfaction: Preliminary Findings on the Mediating Role of Work-Life Balance

积极心态与工作满意度之间的联系:工作与生活平衡的中介作用初步研究

Orkibi, Hod; Brandt, Yaron Ilan